Amicus Therapeutics, Inc.

SILVERCREST ASSET MANAGEMENT GROUP LLC FOLD

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

945,628

Value ($000)

13,466

Weight

0.1%

2020 Q2 - 2025 Q4 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	13,466	0.1%	945,628	12/31/2025
2025 Q3	11/14/2025	7,442	0.0%	944,455	9/30/2025
2025 Q2	8/14/2025	5,548	0.0%	968,231	6/30/2025
2025 Q1	5/15/2025	4,355	0.0%	533,711	3/31/2025
2024 Q4	2/14/2025	5,042	0.0%	535,255	12/31/2024
2024 Q3	11/14/2024	5,742	0.0%	537,639	9/30/2024
2024 Q2	8/15/2024	5,364	0.0%	540,738	6/30/2024
2024 Q1	5/15/2024	4,417	0.0%	374,958	3/31/2024
2023 Q4	2/14/2024	5,093	0.0%	358,925	12/31/2023
2023 Q3	11/14/2023	4,365	0.0%	358,999	9/30/2023
2023 Q2	8/14/2023	3,522	0.0%	280,384	6/30/2023
2023 Q1	5/15/2023	2,649	0.0%	238,896	3/31/2023
2022 Q4	2/14/2023	2,919	0.0%	239,085	12/31/2022
2022 Q3	11/14/2022	4,374	0.0%	418,923	9/30/2022
2022 Q2	8/15/2022	4,614	0.0%	429,630	6/30/2022
2022 Q1	5/16/2022	4,274	0.0%	451,358	3/31/2022
2021 Q4	2/14/2022	5,157	0.0%	446,459	12/31/2021
2021 Q3	11/15/2021	4,249	0.0%	444,893	9/30/2021
2021 Q2	8/16/2021	4,368	0.0%	453,155	6/30/2021
2021 Q1	5/17/2021	3,015	0.0%	305,175	3/31/2021
2020 Q4	2/16/2021	4,016	0.0%	173,922	12/31/2020
2020 Q3	11/16/2020	2,848	0.0%	201,676	9/30/2020
2020 Q2	8/14/2020	3,096	0.0%	205,295	6/30/2020